Fingerprint
Dive into the research topics of 'Alemtuzumab (Campath-1H) therapy for refractory rejections in pediatric heart transplant recipients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Alemtuzumab (Campath-1H) therapy for refractory rejections in pediatric heart transplant recipients
Bibhuti Das, Vivian Dimas, Kristine Guleserian, Chantale Lacelle, Kristin Anton, Lindy Moore, Robert Morrow
Research output: Contribution to journal › Article › peer-review
7
Scopus
citations